http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1233943-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-90 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-505 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-90 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B65G53-58 |
| filingDate | 1968-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1971-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | GB-1233943-A |
| abstract | 1,233,943. Quinazolinone derivatives. SCIENCE UNION ET CIE, SOC. FRANCAISE DE RECHERCHE MEDICALE. 24 Oct., 1969 [31 Oct., 1968], No. 51720/68. Heading C2C. Novel compounds I in which R 1 is 1-5C alkenyl or haloalkenyl, 3-8C cycloalkenyl, arylalkenyl, 2-5C alkynyl or cyclopropyl and R 2 and R 3 are H, halo, 1-5C alkyl or alkoxy, aryl, CF 3 , or R 2 and R 3 together represent -OCH 2 O- and acid addition salts thereof are prepared by condensation of R 1 X (X = halo) with a compound III to give a compound IV followed by reaction with ethyl orthoformate at 100-200 C. while distilling off the ethanol formed. Compounds IV are isolated as intermediates. Pharmaceutical compositions for oral or parenteral use as analgesic, anti-tussive, antiinflammatory and anti-rheumatic agents comprise a compound I together with a suitable carrier. |
| priorityDate | 1968-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 20.